Treatment of hemophilia in developing countries - A journey of a thousand miles

Pediatric Blood and Cancer

Volumn 54, Issue 3, 2010, Pages 348-349

  Gruppo, Ralph A ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTHRITIS; BLEEDING; BLOOD CLOTTING; COST EFFECTIVENESS ANALYSIS; DEVELOPING COUNTRY; DISABILITY; DISEASE SEVERITY; FLUORESCENCE IN SITU HYBRIDIZATION; HEALTH CARE COST; HEALTH CARE PERSONNEL; HEMARTHROSIS; HEMOPHILIA; HUMAN; MORBIDITY; MUSCULOSKELETAL SYSTEM MALFORMATION; PATIENT EDUCATION; PRIORITY JOURNAL; PROPHYLAXIS; QUALITY OF LIFE; SHORT SURVEY; TREATMENT OUTCOME; TREATMENT PLANNING;

BLOOD COAGULATION FACTORS; CHILD, PRESCHOOL; DEVELOPING COUNTRIES; HEMOPHILIA A; HUMANS;

EID: 76749146403     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.22360     Document Type: Short Survey

References (16)

1. Levine PH. Efficacy of self-therapy in hemophilia: A study of 72 patients with hemophilia A and B. N Engl J Med 1974;291:1381-1384.
2. Arnold WE, Hilgartner MW. J Bone Joint Surg Am 1977;59A: 287-305.
3. Manco-Johnson MJ, Nuss R, Geraghty S, et al. Results of secondary prophylaxis in children with severe hemophilia. Am J Hematol 1994;47:113-117.
4. Berntorp E, Boulyjenkov V, Brettler D, et al. Modern treatment of hemophilia. Bull World Health Organ 1995;73:691-701.
5. Lofqvist T, Nilsson IM, Berntorp E, et al. Haemophilia prophylaxis in young patients - A long-term follow-up. J Intern Med 1997; 241:395-400.
6. Manco-Johnson MJ, Abshire TC, Shapiro AD, et al. Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia. N Engl J Med 2007;357:535-544.
7. Nilsson IM, Berntorp E, Lofqvist T, et al. Twenty-five years' experience of prophylactic treatment in severe haemophilia A and B. J Intern Med 1992;232:25-32.
8. Srivastava A. Choice of factor concentrates for haemophilia: A developing world perspective. Haemophilia 2001;7:117-122.
9. Srivastava A. Factor replacement therapy in haemophilia - Are there models for developing countries? Haemophilia 2003;9:391-396.
10. O'Mahony B, Black C. Expanding hemophilia care in developing countries. Semin Thromb Hemost 2005;31:561-568.
11. Chandy M. Management of hemophilia with minimal factor replacement in developing countries: role of ancillary therapy. Semin Thromb Hemost 2005;31:501-506.
12. Heijnen L, Buzzard BB. The role of physical therapy and rehabilitation in the management of hemophilia in developing countries. Semin Thromb Hemost 2005;31:513-517.
13. Martinez-Murillo C, Quintana S, Ambriz R, et al. An economic model of haemophilia in Mexico. Haemophilia 2004;10:9-17.
14. Tlacuilo-Parra A, Villela-Rodriguez J, Garibaldi-Covarrubias R, et al. Functional independence score in hemophilia: A cross-sectional study assessment of Mexican children. Pediatr Blood Cancer (this issue).
15. Poonnoose PM, Manigandan C, Thomas R, et al. Functional independence score in haemophilia (FISH): A new performance-based instrument to measure disability. Haemophilia 2005;11: 598-602.
16. Skinner MW. WFH - The cornerstone of global development: 45 years of progress. Haemophilia 2008;14:1-9.